Human papillomavirus testing for primary cervical cancer screening (Q37266480)

19 August 2017

1 reference

title

Human papillomavirus testing for primary cervical cancer screening. (English)

1 reference

19 August 2017

cervix uterine cancer

1 reference

Magdalena Grce

1

1 reference

PubMed ID

18785808

19 August 2017

Philip Davies

series ordinal

2

1 reference

19 August 2017

1 September 2008

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

19 August 2017

1 reference

19 August 2017

8

1 reference

19 August 2017

5

1 reference

19 August 2017

599-605

1 reference

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

19 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

New molecular tools for efficient screening of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Management of women who test positive for high-risk types of human papillomavirus: the HART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

Could HPV testing become the sole primary cervical screening test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.5.599

21 January 2018

Identifiers

DOI

10.1586/14737159.8.5.599

1 reference

19 August 2017

1 reference

PubMed ID

18785808